Ethnic Differences in Response Rate and Patient‐Reported Outcomes at Baseline and 12 Months Post‐Treatment Among New Zealand Men With Prostate Cancer
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70424 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Eng Ann Toh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Christchurch Hospital, Health New Zealand (Te Whatu Ora) Canterbury Waitaha, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Patient Reported Outcome Measures. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Movember Foundation, Bike for Blokes Charity New Zealand.
Abstract (Originalsprache)
Background
Patient‐reported outcomes (PRO) can be influenced by patient‐ and health system‐related factors. This study examined the effect of contemporary prostate cancer (PCa) treatments (watchful waiting/active surveillance, surgery, external beam radiotherapy and androgen deprivation therapy) on PRO among Māori and non‐Māori in New Zealand (NZ).
Methods
A total of 13 893 men (1155 Māori; 12 828 non‐Māori) with PCa were recruited from the NZ Prostate Cancer Outcome Registry, a national registry for PCa care and PRO. The Expanded Prostate Cancer Index Composite‐26 was used as the patient‐reported outcomes measure (PROM) to assess five disease‐specific functions (urinary incontinence, urinary obstructive/irritative, bowel, sexual and hormonal function) at baseline and 12 months post‐treatment. Multivariable regression analyses were performed to assess between‐group differences and post‐treatment PRO changes with adjustments for confounders.
Results
The PROM response rate in Māori was 1.87 to 2.04 times lower than non‐Māori at baseline and 12 months post‐treatment. Māori reported significantly worse ( p ≤ 0.002) PRO than non‐Māori in urinary incontinence, sexual and hormonal function at baseline but not sexual function ( p = 0.9) at 12 months post‐treatment after adjustments. Both groups demonstrated a similar magnitude of PRO changes 12 months post‐treatment after adjustments, except for surgery and androgen deprivation therapy, where Māori had a significantly lesser decline in hormonal function ( p = 0.003) and sexual function ( p = 0.046) post‐treatment respectively.
Conclusion
Findings from this study can better inform clinicians and patients in choosing a more patient‐tailored PCa treatment in NZ. More work is needed to understand the possible causes for response rate and PRO differences at baseline and 12 months post‐treatment between Māori and non‐Māori.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Christchurch Hospital, Health New Zealand (Te Whatu Ora) Canterbury Waitaha, Christchurch, New Zealand.
- Department of Urology, Auckland City Hospital, Health New Zealand (Te Whatu Ora) Te Tuka Tumai Auckland, Auckland, New Zealand.
- Centre for Health Outcome Measures New Zealand (CHOMNZ), Christchurch, New Zealand.
- Department of Population Health, University of Otago, Christchurch, New Zealand.
ORCID-Profile: Eng Ann Toh, Phil Hider
Förderung
- Movember Foundation
- Bike for Blokes Charity New Zealand
Zitieren
APA
Toh, E. A., White, J., Clarke, J., Hider, P., & Mark, S. (2025). Ethnic Differences in Response Rate and Patient‐Reported Outcomes at Baseline and 12 Months Post‐Treatment Among New Zealand Men With Prostate Cancer. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70424
Vancouver
Toh EA, White J, Clarke J, Hider P, Mark S. Ethnic Differences in Response Rate and Patient‐Reported Outcomes at Baseline and 12 Months Post‐Treatment Among New Zealand Men With Prostate Cancer. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70424
BibTeX
@article{Toh2025,
author = {Toh, Eng Ann and White, Jared and Clarke, Judith and Hider, Phil and Mark, Stephen},
title = {Ethnic Differences in Response Rate and Patient‐Reported Outcomes at Baseline and 12 Months Post‐Treatment Among New Zealand Men With Prostate Cancer},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70424}
}
EUVIMED